Nkarta NKTX
NASDAQ NKTX
$1.79 +0.04 (+2.29%)
As of: Oct 22, 2026 · 11:33 AM EDT

Nkarta (NKTX) Asset Utilization Ratio (2020)

Updated

Nkarta's (NKTX) Asset Utilization Ratio came in at 0.00 for Q4 2020.

Analysis

Nkarta (NKTX) Asset Utilization Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,175.59 Bn 1,144.18 Bn 19.71 Bn 0.62
2 Johnson & Johnson 639.41 Bn 557.93 Bn 17.26 Bn 0.49
3 AbbVie 502.56 Bn 475.67 Bn 12.70 Bn 0.47
4 Merck 375.27 Bn 329.65 Bn 12.21 Bn 0.52
5 Novartis Ag 303.16 Bn 267.15 Bn 11.24 Bn 0.46
6 Astrazeneca 268.63 Bn 242.32 Bn 12.86 Bn 0.51
7 Amgen 242.12 Bn 197.52 Bn 7.24 Bn 0.40
8 Gilead Sciences 193.40 Bn 167.60 Bn 6.22 Bn 0.58
9 Pfizer 172.79 Bn 119.44 Bn 10.94 Bn 0.31
10 Nkarta 133.35 Mn -1.55 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 0.00
API Access

Nkarta Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NKTX&period=max&api_key=YOUR_API_KEY